After analyzing the direct interactions between CPs and BCL-2 or BCL-XL proteins by structural and biochemical approaches, we were curious about their functional effects within cells, especially whether CPs could inhibit a wide panel of leukemia and solid tumor cells like small-molecule inhibitors. The gene discussed is BCL2L1; the disease is leukemia.